Pharmacy & Distribution Market Research Reports & Industry Analysis
The U.S. two-class system is divided into prescription and nonprescription, or over-the-counter (OTC), medicines. The advantage is that OTC medicines are conveniently sold in a number of retail outlets so that medicines are available when consumers need them. This emphasis on consumer empowerment directly serves two of the most fundamental demands of any workable health care system -- access and affordability.
In recent years, a few of the world’s pharmacy-only national systems have recognized the growing need for greater access to safe and effective medications. Japan, the Netherlands, Denmark, the United Kingdom, Italy, and Argentina all have been part of this trend toward granting consumers increased access to medicines in more outlets.
The drug distribution system in the U.S. is highly regulated by the U.S. Food and Drug Administration (FDA) to ensure only those medications that have a wide enough safety margin and that can be safely and effectively used without the help of a health care professional are available without a prescription.
The somewhat controversial notion of adding a third class of drugs to the U.S. system has been panned by experts and regulators including the AMA and FDA. They say creating a third transition class of drugs would create another health care-disadvantaged population -- those without easy access to a pharmacist at convenient times.
Pharmacy & Distribution Industry Research & Market Reports
-
Medical Foods For Inborn Errors Of Metabolism Global Market Opportunities And Strategies To 2034 Including: 1) By Product: Amino Acid-Based Medical Foods; Glytactin With GMP Amino Acid-Modified Infant Formula With Iron; Low-Calcium/Vitamin D-Free Infant Formula With Iron; Low Protein Food 2) By Forms: Powder; Liquids; Gels 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Drugs Stores; Online Pharmacies 4) By Diseases: Phenylketonuria (PKU); Organic Acidurias; Homocystinuria; Disorders Of Leucine Metabolism; Glutaric Acidemia Type I Renal Disease 5) By Age Group: Infants; Weaning; Adolescent; Adults Covering: Fresenius Kabi; Nestlé S.A.; Abbott Laboratories Inc.; Mount Sinai Health System Inc.; Danone SA
... global medical foods for inborn errors of metabolism market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering ... Read More
-
Healthcare EDI Market by Transmission (Value added Network, Point-to-Point), Software (Claims (Submission, Status, Payment, Referral, Remittance), Supply (Procurement, Inventory), Service, End User (Hospital, ASC, Payer), Region - Global Forecast to 2029
... by the rapid digitization of healthcare records and patient data, regulatory compliance requirements, the growing volume of claims submissions, growing demand from the healthcare insurance industry, and cost reductions associated with EDI implementation. The Workgroup ... Read More
-
Healthcare Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033
... The rising healthcare expenditure, growing aging population, stringent regulatory standards, constant technological advancements, increasing focus on patient safety, and rapid growth in the pharmaceutical industry are some of the major factors propelling the market. Healthcare ... Read More
-
Allergy Immunotherapies Market Report by Treatment Type (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)), Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2025-2033
... The market is propelled by the rising prevalence of allergic conditions, increasing awareness about immunotherapy as an effective treatment for allergies, significant developments in immunotherapy treatments and technologies, favorable government policies and funding for allergy ... Read More
-
Pain Management Drugs Market Report by Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, and Others), Indication (Musculoskeletal Pain, Surgical and Trauma Pain, Cancer Pain, Neuropathic Pain, Migraine Pain, Obstetrical Pain, Fibromyalgia Pain, Burn Pain, Dental/Facial Pain, Pediatric Pain, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
... 2025-2033. The market is experiencing robust growth driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies, heightened awareness and education about pain management, the implementation of supportive government and regulatory ... Read More
-
Pharmacy Repackaging Systems
... at a CAGR of 7.3% over the analysis period 2024-2030. Blister Card/Compliance Packaging Systems, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$1.0 Billion by the ... Read More
-
Health Information Exchange (HIE)
... 2030, growing at a CAGR of 12.2% over the analysis period 2024-2030. Private HIE, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$2.4 Billion by the ... Read More
-
Pharmacy Automation
... CAGR of 6.9% over the analysis period 2024-2030. Medication Dispensing Systems, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$3.3 Billion by the end of the ... Read More
-
Pharmacy Benefit Management
... at a CAGR of 3.9% over the analysis period 2024-2030. Specialty Pharmacy Services, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$261.1 Billion by the end ... Read More
-
ePharmacies
... 14.9% over the analysis period 2024-2030. Over-The-Counter (OTC) Drugs, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$127.2 Billion by the end of the analysis period. ... Read More
-
Pharmacy Management Systems
... at a CAGR of 11.5% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$15.5 Billion by the end of ... Read More
-
Healthcare Distribution
... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical Distribution, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis ... Read More
-
Emergency Department Information Systems
... 2030, growing at a CAGR of 11.9% over the analysis period 2024-2030. Enterprise Solutions, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$1.1 Billion by the ... Read More
-
High Volume Dispensing Systems
... 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Systems / Cabinets Component, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3.6 Billion ... Read More
-
Compounding Pharmacy
... CAGR of 4.5% over the analysis period 2024-2030. Oral Products, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$8.6 Billion by the end of the analysis ... Read More
-
Pharmacy Inventory Management Software Solutions and Cabinets
... expected to reach US$11.4 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Decentralized Systems, one of the segments analyzed in the report, is expected to record a 10.2% CAGR ... Read More
-
E-Prescribing Global Market Report 2025
... strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the most comprehensive ... Read More
-
E-Pharmacy Global Market Report 2025
... strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the most comprehensive ... Read More
-
Global Compounding Pharmacy Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033
... Pharmacies; Online PharmaciesCovering: Pfizer Inc.; Alnylam Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; BridgeBio Pharma, Inc.; Intellia Therapeutics Inc. Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; ... Read More
-
Online Vitamin & Supplement Sales in the US - Industry Market Research Report
... boost sales, as older consumers tend to spend more on vitamins and supplements than younger demographics. The COVID-19 pandemic resulted in sales of immune system supporting vitamins and supplements surging, as consumers sought to increase ... Read More
-
U.S. E-Prescribing Market - Focused Insights 2025-2030
... announced that it is integrating e-prescribing and medication management solutions from health technology pioneer DrFirst into its CDS system. In January 2022, Oracle announced its acquisition of Cerner Corporation, a leading supplier of health information ... Read More
-
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2025-2033
... global generic drugs market size reached USD 389.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 674.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.66% during 2025-2033. The ... Read More
-
Online Pharmaceutical Sales in Australia - Industry Market Research Report
... either of these models. Pure-play online pharmacies cannot offer the value-added services (like health advice) that their brick-and-mortar counterparts provide, and they cannot compete on price against the heavy discounters. Regulatory controls governing prescription pharmaceutical ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000
... the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will ... Read More
Research Assistance
